Healthcare provider profile · identity verified

John C Lane, M.D.

Family Practice · FORT SMITH, AR · NPI 1467740225

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	408	39
Potassium Chloride	Potassium Chloride	237	33
Amlodipine Besylate	Amlodipine Besylate	234	31
Atorvastatin Calcium	Atorvastatin Calcium	209	40
Furosemide	Furosemide	208	31
Gabapentin	Gabapentin	144	23
Lisinopril	Lisinopril	144	28
Pantoprazole Sodium	Pantoprazole Sodium	127	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	24
Escitalopram Oxalate	Escitalopram Oxalate	123	17
Metoprolol Succinate	Metoprolol Succinate	123	17
Tamsulosin Hcl	Tamsulosin Hcl	119	20
Donepezil Hcl	Donepezil Hcl	115	14
Sertraline Hcl	Sertraline Hcl	101	16
Metoprolol Tartrate	Metoprolol Tartrate	92	18
Losartan Potassium	Losartan Potassium	90	18
Eliquis	Apixaban	86	suppressed
Gemtesa	Vibegron	85	suppressed
Meloxicam	Meloxicam	78	13
Quetiapine Fumarate	Quetiapine Fumarate	76	suppressed
Omeprazole	Omeprazole	70	17
Tramadol Hcl	Tramadol Hcl	64	14
Clopidogrel	Clopidogrel Bisulfate	61	14
Duloxetine Hcl	Duloxetine Hcl	61	suppressed
Trazodone Hcl	Trazodone Hcl	61	suppressed
Simvastatin	Simvastatin	60	suppressed
Famotidine	Famotidine	54	suppressed
Xarelto	Rivaroxaban	54	suppressed
Memantine Hcl	Memantine Hcl	53	suppressed
Metformin Hcl	Metformin Hcl	53	suppressed
Olanzapine	Olanzapine	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Divalproex Sodium	Divalproex Sodium	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	13
Hydroxyzine Hcl	Hydroxyzine Hcl	45	11
Mirtazapine	Mirtazapine	45	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Latanoprost	Latanoprost	40	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Lorazepam	Lorazepam	39	12
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Carvedilol	Carvedilol	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Ondansetron Odt	Ondansetron	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Prednisone	Prednisone	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Primidone	Primidone	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Colestipol Hcl	Colestipol Hcl	26	suppressed
Rytary	Carbidopa/Levodopa	26	suppressed
Lactulose	Lactulose	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Myrbetriq	Mirabegron	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Ozempic	Semaglutide	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Nystop	Nystatin	19	suppressed
Topiramate	Topiramate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Glycopyrrolate	Glycopyrrolate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Prevalite	Cholestyramine	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Sulfasalazine	Sulfasalazine	17	suppressed
Finasteride	Finasteride	16	suppressed
Admelog	Insulin Lispro	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Humalog	Insulin Lispro	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Propafenone Hcl	Propafenone Hcl	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Nystatin	Nystatin	14	suppressed
Mupirocin	Mupirocin	13	11
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error